Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clobetasone butyrate
Drug ID BADD_D00491
Description Clobetasone is a corticosteroid that is often employed topically as a treatment for a variety of conditions such as eczema, psoriasis, various forms of dermatitis, and also for certain ophthalmologic conditions. Topical clobetasone butyrate has shown minimal suppression of the Hypothalamic-pituitary-adrenal axis.
Indications and Usage In ophthalmology, clobetasone butyrate 0.1% eye drops have been shown to be safe and effective in the treatment of dry eyes in Sjögren's Syndrome.
Marketing Status Not Available
ATC Code D07AB01; S01BA09
DrugBank ID DB13158
KEGG ID D01273
MeSH ID C010893
PubChem ID 71386
TTD Drug ID Not Available
NDC Product Code 52128-153
Synonyms clobetasone butyrate | clobetasone 17-butyrate | 21-chloro-11-dehydro-betamethasone-17-butyrate | Eumovate | Emovate | Trimovate
Chemical Information
Molecular Formula C26H32ClFO5
CAS Registry Number 25122-57-0
SMILES CCCC(=O)OC1(C(CC2C1(CC(=O)C3(C2CCC4=CC(=O)C=CC43C)F)C)C)C(=O)CCl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrophy08.03.04.001--Not Available
Cataract06.06.01.001--
Cushingoid24.08.02.004; 19.07.03.001; 14.11.01.006; 05.01.01.002--
Dermatitis23.03.04.002--Not Available
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Endocrine disorder05.09.01.001--Not Available
Erythema23.03.06.001--Not Available
Glaucoma06.03.01.002--
Glycosuria20.02.01.005--
Hair disorder23.02.06.003--Not Available
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertrichosis23.02.04.002--
Immune system disorder10.02.01.001--Not Available
Infection11.01.08.002--Not Available
Obesity14.03.02.009--
Opportunistic infection11.01.08.007--Not Available
Osteoporosis15.02.03.002; 14.04.04.002--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Rosacea23.02.08.001--Not Available
Secondary adrenocortical insufficiency05.01.02.003; 14.11.01.014--Not Available
Skin atrophy23.01.05.001--
Skin disorder23.03.03.007--Not Available
Skin striae23.01.05.002--Not Available
Telangiectasia24.03.03.003; 23.06.03.001--
Urticaria23.04.02.001; 10.01.06.001--
Weight increased13.15.01.006--
Contusion24.07.06.001; 23.03.11.002; 15.03.01.008; 12.01.06.001--
The 1th Page    1 2    Next   Last    Total 2 Pages